The Exocrine Pancreatic Insufficiency Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Exocrine Pancreatic Insufficiency Market:
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report
According to The Business Research Company’s Exocrine Pancreatic Insufficiency Global Market Report 2024, The exocrine pancreatic insufficiency market size has grown strongly in recent years. It will grow from $2.41 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased awareness and diagnosis, growing prevalence of digestive disorders, aging population and pancreatic function decline, rise in gastrointestinal surgeries..
The exocrine pancreatic insufficiency market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued increase in awareness and screening, expanding geriatric population, rising incidence of chronic diseases, improvements in patient access to healthcare, research and development in digestive health.. Major trends in the forecast period include telehealth and digital health solutions, collaborative research initiatives, focus on pediatric epi, regulatory advances and fast-track designations, market expansion in emerging economies, advancements in healthcare infrastructure..
The rise in chronic diseases is expected to propel the growth of the exocrine pancreatic insufficiency market going forward. Chronic diseases are long-term medical conditions that persist over an extended period, typically three months or more. The prolonged presence of the underlying disease can also increase the likelihood of developing secondary complications like exocrine pancreatic insufficiency, which fuels the better management of chronic conditions through medical interventions and therapies and can lead to longer life spans for individuals with these conditions. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses and is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, the rise in chronic diseases will drive the growth of the exocrine pancreatic insufficiency market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp
The exocrine pancreatic insufficiency market covered in this report is segmented –
1) By Treatment: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments
2) By Diagnosis: Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-1), Other Types
3) By Symptoms: Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End Users: Hospitals, Specialty Clinics, Homecare
Major companies operating in the exocrine pancreatic insufficiency market are focusing on creating patient advocacy groups to support patient-centric product development. Patient advocacy groups in exocrine pancreatic insufficiency (EPI) are organizations dedicated to supporting and advocating for individuals affected by exocrine pancreatic and empowering individuals to learn about their condition and treatment options. For instance, in November 2021, Aimmune Therapeutics, Inc., a US-based biopharmaceutical company specializing in exocrine pancreatic insufficiency (EPI) and chronic pancreatitis treatment, partnered with Mission: Cure, a US-based nonprofit organization dedicated to EPI treatment, to introduce a new online patient community on the HealthUnlocked network. This platform offers crucial support and information to patients with pancreatitis, including exocrine pancreatic insufficiency (EPI). The district serves as a space for patients to connect, share their experiences, and receive support for managing chronic pancreatitis and related conditions.
The exocrine pancreatic insufficiency market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Major Players:
Related Reports:
https://goodprnews.com/climate-tech-market-insights-and-preferences/
https://goodprnews.com/deep-brain-stimulation-systems-market-strategies/
https://topprnews.com/climate-tech-market-landscape-key-insights/
https://topprnews.com/deep-brain-stimulation-systems-market-resilience/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Plasma powder is a protein-rich ingredient derived from the spray-drying of plasma,…
Overview and Scope A pedestrian bridge is a constructed framework spanning a railway, river, or…
Overview and Scope Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic…
Overview and Scope A neurological biomarker is a substance that provides objective and quantifiable information…
Overview and Scope Home insurance is a policy that pays for expenses and damage to…
Overview and Scope Extended-release drugs are a dosage form made to release the medication over…